Buy Neurocrine Biosciences Stock | NBIX Stock Price & Latest News | Public
NBIX

Neurocrine Biosciences

$0.00 (0.00%)Today

    About NBIX

    Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocri...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.81
    0.33
    -0.14
    -0.62
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.68

    Actual EPS
    Q4 2020

    Stats

    Market Cap$9,22B
    Volume20,38k
    Price-to-Earnings Ratio106.36
    Dividend Rate
    Dividend Yield
    1 Year High$136.26
    1 Year Low$72.14
    Open$98.00
    High$99.36
    Low$96.52

    Buy any stock with any amount of money.

    Download the App
    Download the app